Histopathologic subtype-specific genomic profiles of renal cell carcinomas identified by high-resolution whole-genome single nucleotide polymorphism array analysis

Oncology Letters

Volumn 1, Issue 6, 2010, Pages 1073-1078

  Yokomizo, Akira ^a   Yamamoto, Ken ^b   Furuno, Kenji ^b   Shiota, Masaki ^a   Tatsugami, Katsunori ^a   Kuroiwa, Kentaro ^a   Naito, Seiji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Comparative genomic hybridization; Renal cell carcinoma; Single nucleotide polymorphism array

Indexed keywords

DNA;

ARTICLE; CANCER CLASSIFICATION; CHROMOSOME 10; CHROMOSOME 11Q; CHROMOSOME 13; CHROMOSOME 17; CHROMOSOME 18Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 2; CHROMOSOME 22P; CHROMOSOME 22Q; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 6; CHROMOSOME 8; CHROMOSOME DELETION; CHROMOSOME LOSS; CLINICAL ARTICLE; CYTOGENETICS; GENOME; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; ONCOGENE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 77957940956     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2010.187     Document Type: Article

References (16)

1. Thoenes W, Storkel S and Rumpelt HJ: Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181: 125-143, 1986.
2. Monzon FA, Hagenkord JM, Lyons-Weiler MA, et al: Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors. Mod Pathol 21: 599-608, 2008.
3. Herrmann E, Brinkmann OA, Bode ME, et al: Histologic subtype of metastatic renal cell carcinoma predicts response to combined immunochemotherapy with interleukin 2, interferon alpha and 5-fluorouracil. Eur Urol 51: 1625-1631, 2007.
4. Clifford SC, Prowse AH, Affara NA, Buys CH and Maher ER: Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosomes Cancer 22: 200-209, 1998.
5. Eto M and Naito S: Molecular targeting therapy for renal cell carcinoma. Int JClin Oncol 11: 209-213, 2006.
6. Mulders P: Vascular endothelial growth factor and mTOR pathways in renal cell carcinoma: differences and synergies of two targeted mechanisms. BJUInt 104: 1585-1589, 2009.
7. Yoshimoto T, Matsuura K, Karnan S, et al: High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. JPathol 213: 392-401, 2007.
8. Peiffer DA, Le JM, Steemers FJ, et al: High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res 16: 1136-1148, 2006.
9. Chen M, Ye Y, Yang H, et al: Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays. Int JCancer 125: 2342-2348, 2009.
10. Yokomizo A, Mai M, Tindall DJ, et al: Over expression of the wild type p73 gene in human bladder cancer. Oncogene 18: 1629-1633, 1999.
11. Pfeifer D, Pantic M, Skatulla I, et al: Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood 109: 1202-1210, 2007.
12. Choueiri TK, Plantade A, Elson P, et al: Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma. JClin Oncol 26: 127-131, 2008.
13. Higgins JP: Gene array studies in renal neoplasia. ScientificWorldJournal 6: 502-511, 2006.
14. Thrash-Bingham CA, Salazar H, Freed JJ, Greenberg RE and Tartof KD: Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology. Cancer Res 55: 6189-6195, 1995.
15. Klatte T, Pantuck AJ, Said JW, et al: Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma. Clin Cancer Res 15: 1162-1169, 2009.
16. Speicher MR, Schoell B, du Manoir S, et al: Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am JPathol 145: 356-364, 1994.